Results 121 to 130 of about 10,565,775 (206)

Dose-dependent pharmacokinetics and acute effects of intravenous bolus N,N-dimethyltryptamine: double-blind, randomized versus open-label dose-escalation administration study in healthy participants. [PDF]

Transl Psychiatry
Erne L, Mueller L, Straumann I, Ademaj B, Eckert A, Vukalovic I, Valenta J, Luethi D, Liechti ME, Vogt SB.   +9 more
europepmc   +1 more source

We Licked the Toads so You Don't Have to: A Comprehensive Analysis of the Chemical Syntheses of the Classical Psychedelics Bufotenin(e) and 5-Methoxy-N,N-Dimethyltryptamine. [PDF]

ChemMedChem
Homon A, Laramie J, Hayward JJ, Trant JF.   +3 more
europepmc   +1 more source

Enlightening the "Spirit Molecule": Photomodulation of the 5-HT_2A Receptor by a Light-Controllable N,N-Dimethyltryptamine Derivative. [PDF]

Angew Chem Int Ed Engl, 2022
Gerwe H, He F, Pottie E, Stove C, Decker M.   +4 more
europepmc   +1 more source

Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT. [PDF]

Psychopharmacology (Berl), 2022
Barker SA.
europepmc   +1 more source

Disintegration of Default Mode: Functional MRI Insights Into N,N-Dimethyltryptamine (DMT), Consciousness, and Subcortical Connectivity. [PDF]

Cureus
Avakian A.
europepmc   +1 more source

A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression. [PDF]

Front Psychiatry, 2023
Reckweg JT, van Leeuwen CJ, Henquet C, van Amelsvoort T, Theunissen EL, Mason NL, Paci R, Terwey TH, Ramaekers JG.   +8 more
europepmc   +1 more source

The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT). [PDF]

J Neurochem, 2022
Reckweg JT, Uthaug MV, Szabo A, Davis AK, Lancelotta R, Mason NL, Ramaekers JG.   +6 more
europepmc   +1 more source

Detection and Quantification of Psychoactive N,N‑Dimethyltryptamine in Ayahuasca Brews by Ambient Ionization High-Resolution Mass Spectrometry

ACS Omega, 2020
Megan I. Chambers, Meghan G. Appley, Cameron M. Longo, Rabi A. Musah   +3 more
doaj   +1 more source

Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression. [PDF]

Neuropsychopharmacology
Falchi-Carvalho M, Palhano-Fontes F, Wießner I, Barros H, Bolcont R, Laborde S, Ruschi B Silva S, Montanini D, C Barbosa D, Teixeira E, Florence-Vilela R, Almeida R, K A de Macedo R, Arichelle F, J Pantrigo É, V Costa-Macedo J, da Cruz Nunes JA, de Araújo Costa Neto LA, Nunes Ferreira LF, Dantas Corrêa L, da Costa Bezerra RB, Arcoverde E, Galvão-Coelho N, B Araujo D.   +23 more
europepmc   +1 more source

A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers. [PDF]

Front Pharmacol, 2021
Reckweg J, Mason NL, van Leeuwen C, Toennes SW, Terwey TH, Ramaekers JG.   +5 more
europepmc   +1 more source